Delivery Order SPE2DB20D3101-SPE2DB25FRVB1
- Not listed
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 1,000 mg tablets of Lanthanum Carbonate for $1,647.94. The contract has a completion date of February 21, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is issued under an indefinite delivery contract (IDC) with DLA Troop Support Medical with a potential value of up to...
- This federal contract award, worth $4,434.84, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,559,458,904 tablets of Lanthanum Carbonate 1,000 mg, a medication used to treat certain conditions. The contract has a completion date of December 28, 2022 and is structured as a Firm Fixed Price Delivery Order. No set-aside designation was used for this award....
- Amerisourcebergen Drug Corp has received a firm fixed price delivery order valued at one thousand one hundred sixty-seven dollars and sixty cents ($1,167.60) from the Defense Logistics Agency (DLA) Troop Support Medical supply chain program. As the prime contractor, Amerisourcebergen will deliver five hundred (500) milligram chewable lanthanum carbonate tablets to the DLA distribution center located in Conshohocken, Pennsylvania by November second, twenty twenty-three. The delivery order was...
- The Defense Logistics Agency awarded a delivery order valued at $1,390.94 to AmerisourceBergen Drug Corp for Lithium Carbonate ER 450 mg tablets (100-count units) on August 18, 2025, with an ultimate completion date of August 19, 2025. This non-set-aside, firm fixed-price contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $1,516.44 to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Lansoprazole DR 15 mg Orally Disintegrating Tablets in unit dose packaging (100 count). This firm fixed price, competitively awarded delivery order is scheduled for completion by September 9, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award was made without any set-aside designation, reflecting open...
- The Defense Logistics Agency awarded a delivery order valued at $2,486.78 to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Lansoprazole DR 30 mg orally disintegrating tablets in unit-dose packaging (100 count). This is a firm fixed price, non-set-aside delivery order with a completion date of September 2, 2025, to be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency Troop Support Medical awarded a $54,920 delivery order to Amerisourcebergen Drug Corporation for the supply of 4561324296 lithium carbonate extended release 450 mg tablets packaged in bottles of 100 tablets each. The place of performance for this firm fixed price contract is Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The contract period of performance spans from June 23, 2023 through June 26, 2023. No subcontractors or set aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Linzess 72 mg capsules in a 30-count unit pack, with a contract ceiling value of $1,495.59 and an ultimate completion date of July 21, 2025. This firm fixed price delivery order represents a non-competitive award and is classified as a child contract under AmerisourceBergen's larger federal contracting framework. The performance location is the company's corporate office in...
- The Defense Logistics Agency (DLA) awarded a $3,061.96 delivery order to AmerisourceBergen Drug Corp for LINZESS 145 micrograms capsules (30-count units) on September 9, 2025, with completion targeted for September 10, 2025. This firm fixed price contract represents a non-competitive delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The award supports the company's...
- The Defense Logistics Agency awarded a $11,335.78 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Linzess 290 microgram capsules in quantities of 30 units. This firm fixed-price contract represents a competitively awarded, non-set-aside procurement with a completion date of August 19, 2025. The product will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRVB1Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lanthanum Carbonate 1,000 mg chewable tablets in a quantity of 10 units, with a contract ceiling value of $3,060.00. The award was issued on September 11, 2025, with an ultimate completion date of September 12, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal medical supply vendor, AmerisourceBergen Drug Corp supplies an extensive range of pharmaceutical products and medical supplies to support military healthcare systems and other federal health programs. The company's comprehensive contract portfolio demonstrates its capability to fulfill diverse federal medical procurement requirements, including specialty medications, generic drugs, vaccines, and related healthcare commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 9/11/25 |